Blood Test Reveals How Lung Cancer Outsmarts Osimertinib in Landmark Liquid Biopsy Study
A Thai prospective study used plasma-based 52-gene sequencing to map how T790M-positive lung cancers resist osimertinib, finding heterogeneous resistance mutations ...
